MMP9 and colorectal cancer: Indeed, Ayoup et al. evaluated the antineoplastic potential of novel dual MMP-9/MAO-A inhibitors and described a potent migratory-suppressing effect along with significant HIF1α downregulation in HCT116 human colorectal cancer cells that overexpress MMP-9 and MAO-A [91].